Algo version: 0.98b
Lionco Pharmaceutical is listed at the SHH Exchange
Lionco Pharmaceutical [603669.SS]
SHH Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Lionco Pharmaceutical stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Lionco Pharmaceutical pays dividends. Last time was Tuesday 5th of July 2022 where the investors holding the stock on Tuesday 5th of July 2022 were paid CNY0.1 per share. Over the last 8 times between 2016 and 2022, Lionco Pharmaceutical has paid CNY2.07 with an average of CNY0.26 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Lionco Pharmaceutical 10 years ago, but if you had invested on Monday 21st of October 2019 when the price was CNY5.49, you would have made a loss of CNY-1.143 per share or -20.81%

Yes, the average daily trading liquidity for Lionco Pharmaceutical is CNY4.13 million. You should therefore be able to get in and out of your positions relatively fast.

Lionco Pharmaceutical has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Lionco Pharmaceutical to be high [0.85 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.